Insulin glargine (Insulin U300) - Sanofi
At a glance
- Drug Originator Sanofi
- Drug Class Antihyperglycaemics; Insulins; Pancreatic hormones
- Mechanism of Action Insulin receptor agonists; Ornithine decarboxylase stimulants; Phosphokinase stimulants; Protein tyrosine kinase stimulants
- USA Patent Applicants SANOFI US SERVICES
- USA Patents 4
- BLAs 1
- International Patents 64

Disclaimer